Welcome to Cardiology Today – Recorded March 16, 2026. This episode summarizes 5 key cardiology studies on topics like Donor-specific antibody and Heart transplant rejection. Key takeaway: Kidney Injury Drives Diuretic Resistance in A. H. F..
Article Links:
Article 1: Net Prolongation of Life in Advanced Heart Failure: An Intentional Strategy of Durable LVAD Therapy Followed by Heart Transplantation. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 2: Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: results from the Trifecta-Heart study. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 3: Kidney tubule injury is associated with sodium avidity and diuretic responsiveness in acute heart failure. (ESC heart failure)
Article 4: Effect of Hypertension Duration on the Associations Between Intensive Blood Pressure Control and Cardiac, Vascular, and Kidney Organ Damage. (Journal of the American Heart Association)
Article 5: Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction. (Journal of the American Heart Association)
Full episode page: https://podcast.explainheart.com/podcast/kidney-injury-drives-diuretic-resistance-in-a-h-f-03-16-26/
Featured Articles
Article 1: Net Prolongation of Life in Advanced Heart Failure: An Intentional Strategy of Durable LVAD Therapy Followed by Heart Transplantation.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41833594
Summary: Heart transplantation is an established gold standard therapy for end-stage systolic heart failure, showing a median survival of approximately 10 to 13 years. For younger patients under 50 years of age, the utility of heart transplantation for lifetime management is limited by low re-transplantation rates. Durable left ventricular assist device support is also an established surgical option for these patients. The article identifies an intentional strategy of utilizing durable left ventricular assist device therapy followed by heart transplantation to achieve net prolongation of life in advanced heart failure.
Article 2: Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: results from the Trifecta-Heart study.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41833593
Summary: Antibody-mediated rejection in heart transplants frequently presents without donor-specific antibodies, posing a diagnostic challenge. The Trifecta-Heart study provided characterization of rejection in 212 heart endomyocardial biopsies through the Molecular Microscope Diagnostic System and histology. This research distinguished molecular differences between donor-specific antibody-negative and donor-specific antibody-positive antibody-mediated rejection. Donor-derived cell-free D. N. A., a biomarker for transplant injury, was concurrently measured at the time of biopsy to enhance the understanding of these distinct rejection phenotypes.
Article 3: Kidney tubule injury is associated with sodium avidity and diuretic responsiveness in acute heart failure.
Journal: ESC heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41832743
Summary: Greater sodium avidity in patients with acute heart failure is a known indicator of worse clinical outcomes. This study evaluated 339 participants from the R. O. S. E. hyphen A. H. F. trial, which included patients hospitalized for acute heart failure with kidney dysfunction. The study found that kidney tubule injury, as assessed by urinary biomarkers such as kidney injury molecule-1, N-acetyl-beta-D-glucosaminidase, and neutrophil gelatinase-associated lipocalin, is associated with both increased sodium avidity and impaired diuretic responsiveness. This association provides insight into the underlying mechanisms contributing to poor outcomes in acute heart failure.
Article 4: Effect of Hypertension Duration on the Associations Between Intensive Blood Pressure Control and Cardiac, Vascular, and Kidney Organ Damage.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41823241
Summary: Intensive systolic blood pressure treatment is a crucial strategy to mitigate cardiovascular disease risk in long-standing hypertension, with target organ damage being a critical intermediate phenotype. This study utilized data from 8442 participants in the S. T. E. P. trial (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients). The research precisely evaluated the impact of hypertension duration on the associations between intensive blood pressure control and improvements in cardiac, vascular, and kidney organ damage. This evaluation addresses a key gap in understanding how long-term hypertension affects the benefits of aggressive blood pressure management.
Article 5: Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41823240
Summary: Heart failure with preserved ejection fraction is characterized by chronic low-grade inflammation, which impacts endothelial function, glycocalyx integrity, and barrier permeability. Glycocalyx degradation, specifically involving biomarkers hyaluronan and syndecan-1, is implicated in the pathophysiology of heart failure with preserved ejection fraction. This study established associations between these glycocalyx degradation biomarkers and both patient characteristics and clinical outcomes in heart failure with preserved ejection fraction. These findings link endothelial glycocalyx shedding to the development and progression of the disease.
Transcript
Today’s date is March 16, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Net Prolongation of Life in Advanced Heart Failure: An Intentional Strategy of Durable LVAD Therapy Followed by Heart Transplantation. Heart transplantation is an established gold standard therapy for end-stage systolic heart failure, showing a median survival of approximately 10 to 13 years. For younger patients under 50 years of age, the utility of heart transplantation for lifetime management is limited by low re-transplantation rates. Durable left ventricular assist device support is also an established surgical option for these patients. The article identifies an intentional strategy of utilizing durable left ventricular assist device therapy followed by heart transplantation to achieve net prolongation of life in advanced heart failure.
Article number two. Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: results from the Trifecta-Heart study. Antibody-mediated rejection in heart transplants frequently presents without donor-specific antibodies, posing a diagnostic challenge. The Trifecta-Heart study provided characterization of rejection in 212 heart endomyocardial biopsies through the Molecular Microscope Diagnostic System and histology. This research distinguished molecular differences between donor-specific antibody-negative and donor-specific antibody-positive antibody-mediated rejection. Donor-derived cell-free D. N. A., a biomarker for transplant injury, was concurrently measured at the time of biopsy to enhance the understanding of these distinct rejection phenotypes.
Article number three. Kidney tubule injury is associated with sodium avidity and diuretic responsiveness in acute heart failure. Greater sodium avidity in patients with acute heart failure is a known indicator of worse clinical outcomes. This study evaluated 339 participants from the R. O. S. E. hyphen A. H. F. trial, which included patients hospitalized for acute heart failure with kidney dysfunction. The study found that kidney tubule injury, as assessed by urinary biomarkers such as kidney injury molecule-1, N-acetyl-beta-D-glucosaminidase, and neutrophil gelatinase-associated lipocalin, is associated with both increased sodium avidity and impaired diuretic responsiveness. This association provides insight into the underlying mechanisms contributing to poor outcomes in acute heart failure.
Article number four. Effect of Hypertension Duration on the Associations Between Intensive Blood Pressure Control and Cardiac, Vascular, and Kidney Organ Damage. Intensive systolic blood pressure treatment is a crucial strategy to mitigate cardiovascular disease risk in long-standing hypertension, with target organ damage being a critical intermediate phenotype. This study utilized data from 8442 participants in the S. T. E. P. trial (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients). The research precisely evaluated the impact of hypertension duration on the associations between intensive blood pressure control and improvements in cardiac, vascular, and kidney organ damage. This evaluation addresses a key gap in understanding how long-term hypertension affects the benefits of aggressive blood pressure management.
Article number five. Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction. Heart failure with preserved ejection fraction is characterized by chronic low-grade inflammation, which impacts endothelial function, glycocalyx integrity, and barrier permeability. Glycocalyx degradation, specifically involving biomarkers hyaluronan and syndecan-1, is implicated in the pathophysiology of heart failure with preserved ejection fraction. This study established associations between these glycocalyx degradation biomarkers and both patient characteristics and clinical outcomes in heart failure with preserved ejection fraction. These findings link endothelial glycocalyx shedding to the development and progression of the disease.
Thank you for listening. Don’t forget to subscribe.
Keywords
Donor-specific antibody, Heart transplant rejection, Donor-derived cell-free D. N. A., Sodium avidity, Target organ damage, Heart failure with preserved ejection fraction, Endothelial function, End-stage heart failure, Kidney tubule injury, Kidney injury molecule-1, Lifetime management, Antibody-mediated rejection, Syndecan-1, Systolic blood pressure, Diuretic responsiveness, Glycocalyx degradation, Cardiovascular disease risk, Hypertension duration, Hyaluronan, Intensive blood pressure control, Molecular Microscope Diagnostic System, Heart transplantation, Acute heart failure, Systolic heart failure, Left ventricular assist device.
About
Concise summaries of cardiovascular research for professionals.
Subscribe • Share • Follow
The post Kidney Injury Drives Diuretic Resistance in A. H. F. 03/16/26 first appeared on Cardiology Today.